CHAPS

The main aim of the trial is to measure the difference in incidence of post-thrombotic syndrome after first, acute DVT between standard clinical care (anticoagulation) and the intervention arm (a graduated compression stocking and the standard clinical care (anticoagulation).

Image

Chief Investigator: Professor Alun Davies

Number and location of participating sites / geographical scope (by region/ country): UK – 11 sites

Funder: NIHR HTA

ISRCTN number: ISRCTN: 73041168

Clinical Trials Gov number: NCT04103112

Start and End date

Of grant award: 1 May 2019 - 1 Feb 2023

Of recruitment: 1 Nov 2019 - 1 Nov 2021

Current status: Open

Website: https://www.imperial.ac.uk/department-surgery-cancer/research/surgery/clinical-trials/chaps-trial/

Sponsor:  Imperial College London https://www.imperial.ac.uk/  

Chief Investigator: Professor Alun H Davies Professor of Vascular Surgery & Consultant Surgeon Department of Vascular Surgery 4th Floor, East Wing Charing Cross Hospital Fulham Palace Road London, W6 8RF a.h.davies@imperial.ac.uk

Trial Manager Ms Rebecca Lawton, Clinical Trial Manager: CHAPS / GAPS Imperial College London Section of Vascular Surgery Room 14, 4th Floor East Wing Charing Cross Hospital Fulham Palace Road London W6 8RF r.lawton@imperial.ac.uk

UK GDPR Privacy Statement: TBC

ECTU Involvement: Statistics/Database